vs
帕可Bio（PACB）与RAPID MICRO BIOSYSTEMS, INC.（RPID）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是RAPID MICRO BIOSYSTEMS, INC.的4.0倍（$44.6M vs $11.3M）。帕可Bio净利率更高（-90.4% vs -110.8%，领先20.3%）。RAPID MICRO BIOSYSTEMS, INC.同比增速更快（37.3% vs 13.8%）。RAPID MICRO BIOSYSTEMS, INC.自由现金流更多（$-3.3M vs $-19.9M）。过去两年RAPID MICRO BIOSYSTEMS, INC.的营收复合增速更高（41.8% vs 7.3%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
RAPID MICRO BIOSYSTEMS, INC. 是生命科学领域的技术企业，专注于为生物制药厂商、合同研发生产机构等客户提供自动化微生物检测及质控解决方案，可大幅缩短检测周期、提升检测精度，业务覆盖北美、欧洲、亚太等全球核心市场。
PACB vs RPID — 直观对比
营收规模更大
PACB
是对方的4.0倍
$11.3M
营收增速更快
RPID
高出23.5%
13.8%
净利率更高
PACB
高出20.3%
-110.8%
自由现金流更多
RPID
多$16.6M
$-19.9M
两年增速更快
RPID
近两年复合增速
7.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $11.3M |
| 净利润 | $-40.4M | $-12.5M |
| 毛利率 | 37.1% | — |
| 营业利润率 | -92.3% | -108.2% |
| 净利率 | -90.4% | -110.8% |
| 营收同比 | 13.8% | 37.3% |
| 净利润同比 | -1802.7% | -29.3% |
| 每股收益（稀释后） | $-0.11 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBRPID
| Q4 25 | $44.6M | $11.3M | ||
| Q3 25 | $38.4M | $7.8M | ||
| Q2 25 | $39.8M | $7.3M | ||
| Q1 25 | $37.2M | $7.2M | ||
| Q4 24 | $39.2M | $8.2M | ||
| Q3 24 | $40.0M | $7.6M | ||
| Q2 24 | $36.0M | $6.6M | ||
| Q1 24 | $38.8M | $5.6M |
净利润PACBRPID
| Q4 25 | $-40.4M | $-12.5M | ||
| Q3 25 | $-38.0M | $-11.5M | ||
| Q2 25 | $-41.9M | $-11.9M | ||
| Q1 25 | $-426.1M | $-11.3M | ||
| Q4 24 | $2.4M | $-9.7M | ||
| Q3 24 | $-60.7M | $-11.3M | ||
| Q2 24 | $-173.3M | $-12.6M | ||
| Q1 24 | $-78.2M | $-13.3M |
毛利率PACBRPID
| Q4 25 | 37.1% | — | ||
| Q3 25 | 41.4% | — | ||
| Q2 25 | 36.9% | — | ||
| Q1 25 | -3.7% | — | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 25.0% | — | ||
| Q2 24 | 16.5% | — | ||
| Q1 24 | 29.1% | — |
营业利润率PACBRPID
| Q4 25 | -92.3% | -108.2% | ||
| Q3 25 | -101.1% | -145.1% | ||
| Q2 25 | -112.8% | -167.3% | ||
| Q1 25 | -1154.5% | -161.8% | ||
| Q4 24 | -390.1% | -124.5% | ||
| Q3 24 | -160.3% | -158.3% | ||
| Q2 24 | -488.3% | -202.1% | ||
| Q1 24 | -209.6% | -254.4% |
净利率PACBRPID
| Q4 25 | -90.4% | -110.8% | ||
| Q3 25 | -98.9% | -146.8% | ||
| Q2 25 | -105.4% | -163.3% | ||
| Q1 25 | -1146.8% | -156.3% | ||
| Q4 24 | 6.0% | -117.6% | ||
| Q3 24 | -151.9% | -148.9% | ||
| Q2 24 | -481.3% | -190.1% | ||
| Q1 24 | -201.4% | -237.4% |
每股收益（稀释后）PACBRPID
| Q4 25 | $-0.11 | $-0.26 | ||
| Q3 25 | $-0.13 | $-0.26 | ||
| Q2 25 | $-0.14 | $-0.27 | ||
| Q1 25 | $-1.44 | $-0.26 | ||
| Q4 24 | $-0.44 | $-0.22 | ||
| Q3 24 | $-0.22 | $-0.26 | ||
| Q2 24 | $-0.64 | $-0.29 | ||
| Q1 24 | $-0.29 | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $20.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.3M | $33.2M |
| 总资产 | $784.1M | $74.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PACBRPID
| Q4 25 | $279.5M | $20.0M | ||
| Q3 25 | $298.7M | $18.9M | ||
| Q2 25 | $314.7M | $18.3M | ||
| Q1 25 | $343.1M | $18.9M | ||
| Q4 24 | $389.9M | $16.9M | ||
| Q3 24 | $471.1M | $22.0M | ||
| Q2 24 | $509.8M | $37.1M | ||
| Q1 24 | $561.9M | $22.4M |
股东权益PACBRPID
| Q4 25 | $5.3M | $33.2M | ||
| Q3 25 | $36.1M | $44.3M | ||
| Q2 25 | $61.5M | $54.5M | ||
| Q1 25 | $91.6M | $65.5M | ||
| Q4 24 | $506.6M | $75.4M | ||
| Q3 24 | $453.1M | $84.4M | ||
| Q2 24 | $492.7M | $94.6M | ||
| Q1 24 | $649.0M | $105.9M |
总资产PACBRPID
| Q4 25 | $784.1M | $74.9M | ||
| Q3 25 | $803.2M | $84.4M | ||
| Q2 25 | $825.5M | $75.6M | ||
| Q1 25 | $860.8M | $85.4M | ||
| Q4 24 | $1.3B | $98.2M | ||
| Q3 24 | $1.5B | $105.8M | ||
| Q2 24 | $1.5B | $117.1M | ||
| Q1 24 | $1.7B | $127.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $-3.2M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $-3.3M |
| 自由现金流率自由现金流/营收 | -44.6% | -29.6% |
| 资本支出强度资本支出/营收 | 1.9% | 0.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-114.1M | $-31.9M |
8季度趋势，按日历期对齐
经营现金流PACBRPID
| Q4 25 | $-19.1M | $-3.2M | ||
| Q3 25 | $-18.7M | $-9.1M | ||
| Q2 25 | $-29.4M | $-9.7M | ||
| Q1 25 | $-44.1M | $-9.1M | ||
| Q4 24 | $-30.6M | $-9.9M | ||
| Q3 24 | $-45.5M | $-8.6M | ||
| Q2 24 | $-54.3M | $-10.1M | ||
| Q1 24 | $-75.7M | $-15.5M |
自由现金流PACBRPID
| Q4 25 | $-19.9M | $-3.3M | ||
| Q3 25 | $-18.8M | $-9.1M | ||
| Q2 25 | $-29.9M | $-10.1M | ||
| Q1 25 | $-45.4M | $-9.4M | ||
| Q4 24 | $-32.3M | $-10.0M | ||
| Q3 24 | $-46.3M | $-8.8M | ||
| Q2 24 | $-55.7M | $-10.6M | ||
| Q1 24 | $-79.6M | $-16.1M |
自由现金流率PACBRPID
| Q4 25 | -44.6% | -29.6% | ||
| Q3 25 | -48.9% | -116.4% | ||
| Q2 25 | -75.3% | -138.6% | ||
| Q1 25 | -122.3% | -130.2% | ||
| Q4 24 | -82.3% | -121.8% | ||
| Q3 24 | -115.7% | -116.0% | ||
| Q2 24 | -154.8% | -159.8% | ||
| Q1 24 | -205.0% | -287.1% |
资本支出强度PACBRPID
| Q4 25 | 1.9% | 0.8% | ||
| Q3 25 | 0.2% | 0.9% | ||
| Q2 25 | 1.4% | 5.0% | ||
| Q1 25 | 3.7% | 4.4% | ||
| Q4 24 | 4.1% | 1.2% | ||
| Q3 24 | 2.0% | 2.9% | ||
| Q2 24 | 4.1% | 6.9% | ||
| Q1 24 | 10.0% | 10.4% |
现金转化率PACBRPID
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -12.93× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
RPID
| Products | $9.3M | 83% |
| Services | $2.0M | 17% |
